Abstract

In the Guidelines for Physicians and Urologists “Watchful Waiting” for Benign Prostatic Hyperplasia (BPH) should be Replaced with Thermobalancing Therapy that Treats Prostate Effectively, Cost-Effectively and Safely

Highlights

  • Primary care physician is the first contact for screening for benign prostatic hyperplasia (BPH), conducting timely diagnostic work, and initiating relevant therapy

  • Primary care physician has an important role with the identification and early treatment of bothersome urinary symptoms caused by BPH [2]

  • It is important as the prevalence of lower urinary tract symptoms (LUTS)/BPH increases with age, and the burden on the healthcare system and society may increase due to the ageing population [3]

Read more

Summary

Watchful Waiting

Guidelines for the management of benign prostatic hyperplasia (BPH), according to the European Association of Urology (EAU), American Urological Association (AUA) and urological associations in other countries, includes pharmacotherapy, “watchful waiting”, surgical options and minimally invasive procedures [6]. DATD facilitates the treatment of the affected prostate by topical application of a special blend of waxes, which can collect the natural radiation of body heat, becoming a source of energy. This special wax mixture is called a thermoelement. DATD by spreading energy towards local micro-hypothermia in the prostate tissue terminates it, stopping enlargement gradually. This leads to the elimination of pain and urine symptoms. This leads to the elimination of pain and urine symptoms. [17,18]

New Understanding of Etiology and Pathophysiology of BPH
Summary and Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call